Merck KGaA Has Loss on Greek Bonds That Paid for Drugs, FTD Says

Greek bonds that Merck KGaA (MRK) received in lieu of payment for drugs delivered to local hospitals lost almost two-thirds of their value, Financial Times Deutschland reported, citing a Merck spokesman. *Merck received bonds worth 55.6 million euros ($72 million) *Bonds covered outstanding bills of 60 million euros incurred between 2007 and 2009 *Greece repaid 12.4 million euros worth of bonds *Merck sold the rest for 8.1 million euros *Bayer AG (BAYN), Fresenius SE and Biotest AG (BIO) also took losses on Greek bonds. Link to Company News: MRK GY <Equity> CN <GO>

To contact the reporter on this story: Eva von Schaper in Munich at evonschaper@bloomberg.net

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net

Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.